226 related articles for article (PubMed ID: 24603686)
1. The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.
Shukla S; Bafna K; Sundar D; Thorat SS
PLoS One; 2014; 9(6):e90637. PubMed ID: 24603686
[TBL] [Abstract][Full Text] [Related]
2. Amarogentin as Topical Anticancer and Anti-Infective Potential: Scope of Lipid Based Vesicular in its Effective Delivery.
Patel K; Kumar V; Verma A; Rahman M; Patel DK
Recent Pat Antiinfect Drug Discov; 2019; 14(1):7-15. PubMed ID: 30210007
[TBL] [Abstract][Full Text] [Related]
3. Contents of therapeutic metabolites in Swertia chirayita correlate with the expression profiles of multiple genes in corresponding biosynthesis pathways.
Padhan JK; Kumar V; Sood H; Singh TR; Chauhan RS
Phytochemistry; 2015 Aug; 116():38-47. PubMed ID: 26028519
[TBL] [Abstract][Full Text] [Related]
4. Detection of intermediates through high-resolution mass spectrometry for constructing biosynthetic pathways for major chemical constituents in a medicinally important herb, Swertia chirayita.
Kumar V; Sood H; Chauhan RS
Nat Prod Res; 2015; 29(15):1449-55. PubMed ID: 25622657
[TBL] [Abstract][Full Text] [Related]
5. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
Oniga SD; Pacureanu L; Stoica CI; Palage MD; Crăciun A; Rusu LR; Crisan EL; Araniciu C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891941
[TBL] [Abstract][Full Text] [Related]
6. Phytochemical investigation of crude methanol extracts of different species of Swertia from Nepal.
Khanal S; Shakya N; Thapa K; Pant DR
BMC Res Notes; 2015 Dec; 8():821. PubMed ID: 26708007
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids.
Taidi L; Maurady A; Britel MR
J Biomol Struct Dyn; 2022 Feb; 40(3):1189-1204. PubMed ID: 32990169
[TBL] [Abstract][Full Text] [Related]
8. Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development.
Singh S; Pandey VP; Naaz H; Singh P; Dwivedi UN
Comput Biol Med; 2013 Jul; 43(6):744-50. PubMed ID: 23668350
[TBL] [Abstract][Full Text] [Related]
9. Potential interaction of natural dietary bioactive compounds with COX-2.
Maldonado-Rojas W; Olivero-Verbel J
J Mol Graph Model; 2011 Sep; 30():157-66. PubMed ID: 21803623
[TBL] [Abstract][Full Text] [Related]
10. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies.
Chaudhary N; Aparoy P
J Biomol Struct Dyn; 2017 Mar; 35(4):868-882. PubMed ID: 26982261
[TBL] [Abstract][Full Text] [Related]
12. Phenolic-linked biochemical rationale for the anti-diabetic properties of Swertia chirayita (Roxb. ex Flem.) Karst.
Phoboo S; Pinto Mda S; Barbosa AC; Sarkar D; Bhowmik PC; Jha PK; Shetty K
Phytother Res; 2013 Feb; 27(2):227-35. PubMed ID: 22523004
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
14. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
[TBL] [Abstract][Full Text] [Related]
15. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice.
Zhang Y; Zhao H; Li H; Cao W; Wang F; Zhang T; Wang SW
Molecules; 2017 May; 22(5):. PubMed ID: 28481234
[TBL] [Abstract][Full Text] [Related]
17. Isoindoline Derivatives of α-Amino Acids as Cyclooxygenase 1 and 2 Inhibitors.
Mancilla-Percino T; Trejo-Muñoz CR; Díaz-Gandarilla JA; Talamás-Rohana P; Guzmán Ramírez JE; Cervantes J; Figueroa Ortíz A
Arch Pharm (Weinheim); 2016 Mar; 349(3):175-85. PubMed ID: 26762192
[TBL] [Abstract][Full Text] [Related]
18. Optimizing nutrient media conditions for continuous production of shoot biomass enriched in major medicinal constituents, amarogentin and mangiferin of endangered medicinal herb,
Gupta R; Sood H
Vegetos; 2022 Aug; ():1-9. PubMed ID: 36061345
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
[TBL] [Abstract][Full Text] [Related]
20. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
